KU 272 (Oxybutynin chloride extended-release 15 mg)
Pill imprint KU 272 has been identified as Oxybutynin chloride extended-release 15 mg.
Oxybutynin is used in the treatment of overactive bladder; urinary incontinence; hyperhidrosis; prostatitis; dysuria and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Oxybutynin 15 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- KU 272
- Strength:
- 15 mg
- Color:
- White
- Size:
- 9.00 mm
- Shape:
- Round
- Availability:
- Rx and/or OTC
- Drug Class:
- Urinary antispasmodics
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Kremers Urban
- National Drug Code (NDC):
- 62175-0272
- Inactive Ingredients:
- lactose anhydrous
lactose monohydrate
mannitol
dextrose, anhydrous
tartaric acid
silicon dioxide
magnesium stearate
cellulose acetate
polyethylene glycol 400
titanium dioxide
ferrosoferric oxide
propylene glycol
hypromellose 2208 (100 mPa.s)
triacetin
| NDC Code | Manufacturer / Repackager |
|---|---|
| 42291-0635 | AvKare, Inc. |
Note: Inactive ingredients may vary.
More about oxybutynin
Consumer resources
- Oxybutynin
- Oxybutynin extended-release tablets
- Oxybutynin gel
- Oxybutynin syrup
- Oxybutynin system
- More (4) »
- Other brands: Ditropan, Ditropan XL, Oxytrol, Gelnique, More (2) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
